Metabolic research
Adipotide
Lyophilized metabolic research compound
Adipotide is a prohibitin-targeting peptidomimetic studied for adipose vasculature signaling in metabolic research, including preclinical and primate obesity literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesPour la recherche en laboratoire uniquement. Pas pour un usage humain ou vétérinaire. Non destiné à diagnostiquer, traiter, guérir, atténuer ou prévenir une maladie.
Conserver scellé, froid, sec et protégé des variations de chaleur. Confirmez le stockage spécifique au produit à l'arrivée.
Emballé pour la stabilité du transit avec une assistance aux commandes disponible pour les itinéraires par temps chaud.
Batch-linked certificate support is available through the documentation desk.
Contexte de recherche
Profil de recherche Adipotide
Adipotide is a targeted peptidomimetic investigated in preclinical metabolic research. Its design links a prohibitin-binding sequence associated with white-adipose vasculature to a pro-apoptotic peptide cargo, allowing researchers to examine targeted vascular disruption, adipose-tissue changes, metabolic markers, and safety observations. Published work includes animal and nonhuman-primate models, with renal findings forming an important part of the experimental record. This material is most relevant to projects studying targeted adipose-vasculature biology rather than incretin receptors, AMPK signaling, or conventional appetite pathways. There is no established human therapeutic evidence, and results should not be generalized beyond the cited models.
Mécanisme proposé
A targeted peptidomimetic that combines a prohibitin-binding motif associated with white-adipose vasculature and a pro-apoptotic D-peptide cargo. The proposed mechanism is selective damage to supporting blood vessels in white fat, followed by loss of adipose tissue.
Effets rapportés dans les études
- Rodent and obese-primate studies reported reduced food intake, loss of body mass and fat mass, and improved insulin-sensitivity markers.
- Histologic studies reported apoptosis and vascular disruption in targeted white-adipose tissue.
- Renal tubular changes and other kidney-related safety findings were important adverse observations in primate research.
Critères de recherche courants
Prohibitin binding, vascular targeting, apoptosis, adipose mass, food intake, body mass, insulin sensitivity, renal chemistry, urinalysis, and kidney histology.
Preuves et limites
Evidence is preclinical, including nonhuman primate work. There is no established human therapeutic evidence, and renal findings are a material limitation.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
What documentation can I request before ordering?
Before ordering, contact support with the product name, selected format, andu2014if availableu2014an order or batch reference to request available batch-linked documentation.
What should I confirm before ordering?
Compare the product name, listed amount, physical form, storage note, price, and documentation route. When the order arrives, match the product and lot or batch reference to the order record and available documentation.